Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATXS Astria Therapeutics Inc

6.53
0.05 (0.77%)
Last Updated: 15:52:57
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Astria Therapeutics Inc NASDAQ:ATXS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   0.05 0.77 6.53 6.53 6.56 6.615 6.19 6.35 227,613 15:52:57   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -72.89M -1.2916 -6.61 365.69M
 Type  Size  Price  Time  Units 
 9 17 6.53 15:56:08 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ATXS News
11/03/202520:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
11/03/202512:07EDGAR2Form 8-K - Current report
28/02/202514:46BWAstria Therapeutics beginnt Phase-3-Zulassungsstudie ALPHA-ORBIT zu Navenibart bei hereditärem Angioödem
28/02/202512:48BWAstria Therapeutics lance l’essai pivot de phase 3 ALPHA-ORBIT du navenibart dans l’œdème angioneurotique héréditaire
28/02/202512:33BWアストリア・セラピューティクス、遺伝性血管性浮腫(HAE)治療向けナベニバートの第3相ピボタル試験ALPHA-ORBITを開始
27/02/202513:00BWAstria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
25/02/202513:00BWAstria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference
Period
Draw mode
Data Downloads for ATXS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)